Boehringer Ingelheim Pharma GmbH & Co. KG
Verified
Biberach, Germany
Not recruiting
Study on the Effects of Food on Two Formulations of Nerandomilast in Healthy Adults
Clinical Trials Concierge
Prefer not to search? Our Concierge searches the trials for you.
What is this trial about?
A plain-language summary of the goals, design and what participants do
This clinical trial is focused on studying the effects of a medication called nerandomilast, which is being tested in healthy adult men and women. The study aims to compare two different formulations of nerandomilast tablets and to see how food affects the new formulation when taken orally. The medication is provided in the form of a film-coated tablet.
The purpose of the study is to understand how the body processes the two formulations of nerandomilast and how food might change this process. Participants will take part in a three-way crossover trial, which means they will receive different formulations of the medication at different times, with and without food. This will help researchers determine the best way to administer the medication for optimal effectiveness.
Throughout the study, participants will be monitored to assess how the medication is absorbed and processed in the body. This will involve measuring the concentration of the medication in the blood over time. The study is designed to ensure the safety and well-being of all participants while gathering important information about the medication's behavior in the body.
The research process
The trial runs in 5 steps – from screening to follow-up. Each step says what happens and what the team monitors.
Who can join the trial?
5 criteria
- Must be a healthy male or female, as determined by the study doctor. This will be based on a complete medical history, a physical exam, checking vital signs like blood pressure and pulse rate, a heart test called a 12-lead ECG, and lab tests.
- Must be between the ages of 18 to 55 years old.
- Must have a Body Mass Index (BMI) between 18.5 to 29.9. BMI is a measure of body fat based on height and weight.
- Must have signed and dated a written consent form, agreeing to participate in the study, according to international and local laws.
- Other criteria may also apply.
Who cannot join the trial?
4 criteria
- Participants must be healthy volunteers. This means you should not have any ongoing medical conditions.
- Participants must be within a specific age range. Please ensure you meet the age requirements for the study.
- Both men and women can participate in the study.
- Participants should not be part of a vulnerable population. This means you should not be in a group that needs special protection, like pregnant women or people who cannot make decisions for themselves.
Clinical Trials Concierge
Prefer not to search? Our Concierge searches the trials for you.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
We usually reply within a few days
Verified sites
All sites with verified contact details – recruitment status may not be available; ask directly
Trial locations
Where you can join this trial
Countries are shaded by recruitment status. Click a recruiting country to ask about joining there.
Not recruitingNot finding your country?
Not sure what to do next?
Joining a clinical trial can seem overwhelming. We guide you step by step, so you know exactly what to expect and how we support you through the process.
Investigated drugs
Nerandomilast is a medication being studied to see how it is absorbed in the body when taken in different forms. The trial is also looking at how eating food might change the way the body processes this medication. This study involves healthy adult men and women who take the medication by mouth. The goal is to understand if the new form of the medication works the same way as the original form and how food might affect its effectiveness. This information can help doctors decide the best way to prescribe this medication in the future.
What is already known about the treatment
Nerandomilast – Nerandomilast is administered orally, meaning it is taken by mouth in the form of a pill or tablet. Currently, it is being studied in clinical trials to understand how different formulations of the medication are absorbed in the body and how food affects its absorption. The main focus of this trial is on healthy volunteers, so it is not yet approved for treating any specific medical conditions. Nerandomilast is being investigated for its potential therapeutic effects, but its exact mechanism of action at the molecular level is still under study. It falls under the pharmacological classification of investigational drugs, as it is not yet available for general medical use.
Investigated diseases
Healthy Volunteer Trial – This is not a disease but a type of clinical study involving individuals who do not have the condition being studied. These participants are typically healthy individuals who volunteer to help researchers understand how a new drug or treatment works in the human body. The trial may involve monitoring the absorption, distribution, metabolism, and excretion of the drug. Healthy volunteer trials are crucial for determining the safety and pharmacokinetics of new treatments before they are tested in patients with the disease. Participants are closely monitored for any side effects or reactions to the treatment. These trials help establish baseline data for future studies involving patients with specific medical conditions.
Trial detailsLast updated 7 Oct 2026
Age18+ yearsPhasePhase ITrial ID2024-511245-18-00Protocol code1305-0029Estimated enrolment15 patientsSponsorBoehringer Ingelheim International GmbH
sourced from the EU Clinical Trials Register and site verification
Want to learn more about this trial or check if you can participate?